Thrombophilia panel

Thrombophilia Genetic Testing

Inherited thrombophilias are conditions where the blood has an increased tendency to clot, leading to serious outcomes such as blood vessel blockages, organ clots, pregnancy loss, and intrauterine growth restriction.

To assess these risks, we examine the following gene regions:

  • Factor V Leiden (G1691A)
  • Factor II – Prothrombin (G20210A)
  • MTHFR C677T and MTHFR A1298C

By carefully evaluating the genetic risks related to clotting disorders, clinicians can offer personalized treatment plans to patients, helping to manage and mitigate these risks effectively especially during pregnancy.

"Genetic information offers an unlimited source of knowledge about human health and development; yet interpreting and applying this information places a huge responsibility on the scientific community."

James Watson